Revenue
2012
2013
2014
2016
2021
2022
2023
2024
2025
Dare Bioscience, Inc. (DARE)
Price$0.8428Cached quote
Net income
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $9,784 | $2.8M | $10.0M | $0 | — | — | — | — | $766,000 | — | $80,000 | $6,000 | $625,000 |
| Gross profit | $734,394 | $9,784 | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross margin | 71.29% | 100.00% | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $5.5M | $14.3M | $21.5M | $30.0M | $30.6M | $20.8M | $8.5M | $6.4M | $984,749 | $27.6M | $25.9M | $11.8M | $9.7M | $15.8M |
| Operating expenses | $14.3M | $23.5M | $33.7M | $41.4M | $39.1M | $27.4M | $14.3M | $16.9M | $11.2M | $630,591 | $37.2M | $20.4M | $15.9M | $22.2M |
| Operating income | −$13.6M | −$23.5M | −$30.9M | −$31.4M | −$39.1M | −$27.4M | −$14.3M | −$16.9M | −$11.2M | −$630,591 | — | — | — | — |
| Operating margin | −1,315.51% | −239,692.20% | −1,101.89% | −313.85% | — | — | — | — | — | −82.32% | — | — | — | — |
| EBITDA | −$11.9M | −$23.4M | −$30.9M | −$31.4M | −$39.0M | −$27.4M | −$14.3M | −$16.9M | −$11.2M | −$369,591 | — | — | — | — |
| EBITDA margin | −1,156.86% | −239,259.61% | −1,100.53% | −313.61% | — | — | — | — | — | −48.25% | — | — | — | — |
| Net income | −$13.4M | −$4.1M | −$30.2M | −$30.9M | −$38.7M | −$27.4M | −$14.3M | −$16.7M | −$11.5M | −$672,687 | −$39.6M | −$23.3M | −$17.1M | −$22.1M |
| Net profit margin | −1,300.66% | −41,430.90% | −1,074.17% | −309.48% | — | — | — | — | — | −87.82% | — | −29,177.50% | −285,716.67% | −3,536.16% |
| Basic EPSper basic share | -$1.20 | -$0.48 | -$4.15 | -$4.44 | -$7.56 | -$10.92 | -$11.64 | -$188.48 | $427.37 | -$97.24 | -$1,872.75 | -$1,920.77 | -$30,072.03 | -$43,685.47 |
| Diluted EPSper diluted share | -$1.20 | -$0.48 | -$4.15 | -$4.44 | -$7.56 | -$10.92 | -$11.64 | -$188.48 | $427.37 | -$97.24 | -$1,872.75 | -$1,920.77 | -$30,072.03 | -$43,685.47 |
Owners
Reported shareholders
4.22%of listed shares
VANGUARD CAPITAL MANAGEMENT LLC640.88K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
VANGUARD CAPITAL MANAGEMENT LLC | 4.22%640.88K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.92%140.09K shares |
US BANCORP \DE\ | 0.80%120.92K shares |
VANGUARD FIDUCIARY TRUST CO | 0.60%91.27K shares |
BlackRock, Inc. | 0.42%64.25K shares |
STATE STREET CORP | 0.31%47.42K shares |
JANE STREET GROUP, LLC | 0.24%36.09K shares |
NORTHERN TRUST CORP | 0.23%34.21K shares |
HRT FINANCIAL LP | 0.15%22.43K shares |
Virtu Financial LLC | 0.10%15.8K shares |
LPL Financial LLC | 0.10%14.89K shares |
RAYMOND JAMES FINANCIAL INC | 0.10%14.86K shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 0.09%13.32K shares |
StoneX Group Inc. | 0.07%11.15K shares |
Objectivity Squared, LLC | 0.07%10.92K shares |
Farther Finance Advisors, LLC | 0.06%9.45K shares |
UBS Group AG | 0.04%6.81K shares |
Vanguard Global Advisers, LLC | 0.02%2.94K shares |
Bay Harbor Wealth Management, LLC | <0.01%1.36K shares |
IFS Advisors, LLC | <0.01%950 shares |
Percentages use 15.17M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data